Atlas FDA

bioMerieux VITEK 2 Gram Positive Cefoxitin Screen, VITEK 2 Gram Positive AST for Oxacillin, VITEK SYSTEMS General Suscep

FDA device recall Z-2817-2018 · posted 2018-08-30 · Terminated

Recall details

Recalling firm
bioMerieux, Inc.
Reason for recall
Customer reports indicated an increase in the rate of non-detected MRSA in association with the VITEK 2 AST-P631 product.
Action taken
bioMerieux sent an Urgent Product Correction Notice letter to their French customers on January 26, 2018. Customer letters in the Americas were sent August 21, 2018. The letters identified the affected product, problem, and actions to be taken. Customers should follow steps outlined in the letter and contact bioMerieux for any additional questions regarding these corrective actions. Note: the actions do not include removal of the product. For any questions or concerns, contact your local bioMerieux representative.
Root cause
Under Investigation by firm
Status
Terminated
Product code
LON
Quantity affected
13,961,320 US
Distribution
Worldwide distribution. US nationwide including Puerto Rico, Bermuda, Brazil, Canada, China, Curacao, Costa Rica, Dominican Republic, Ecuador, France, Guatemala, Indonesia, Israel, Hong Kong, South Ko
Date initiated
2018-01-26
Date posted
2018-08-30
Date terminated
2019-05-20
Location
Durham, NC

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
VITEK 2 GRAM POSITIVE CEFOXITIN SCREEN (K053097)bioMerieux, Inc.2005-12-14